Novavax
NVAX
347 hedge funds and large institutions have $4.34B invested in Novavax in 2020 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 118 increasing their positions, 84 reducing their positions, and 55 closing their positions.
73% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 55
40% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 84
24% more capital invested
Capital invested by funds: $3.5B → $4.34B (+$832M)
12% more funds holding
Funds holding: 311 → 347 (+36)
8.3% more ownership
Funds ownership: 52.7% → 60.99% (+8.3%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
27% less call options, than puts
Call options by funds: $463M | Put options by funds: $638M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$275M |
| 2 |
BlackRock
New York
|
+$88.1M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$76.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$71.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$103M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$56.8M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$41.7M |
| 4 |
Renaissance Technologies
New York
|
-$22.6M |
| 5 |
Two Sigma Investments
New York
|
-$15.6M |
NVAX Hedge Fund Activity: Q4 2020 in Review
347 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2020, worth a combined $4.34B — up 24% from $3.5B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new NVAX positions and 55 closed out — a net gain of 40 holders — while 118 added to existing stakes and 84 trimmed.
The largest buyer was RA Capital Management, adding an estimated $275M. The largest seller was Franklin Resources, cutting an estimated $103M.
- 347 institutional investors held Novavax (NVAX) as of Q4 2020, up from 311 in Q3 2020.
- Funds reported $4.34B of Novavax stock for Q4 2020, up 24% quarter-over-quarter.
- 95 funds opened new Novavax positions in Q4 2020 and 55 closed out, a net change of +40 holders.
- The largest Novavax buyer in Q4 2020 was RA Capital Management, an estimated $275M added.
- The largest Novavax seller in Q4 2020 was Franklin Resources, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2020.